We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.00 | 0.57% | 1,408.00 | 1,403.00 | 1,414.00 | 1,426.00 | 1,365.00 | 1,400.00 | 584,092 | 16:35:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 952.03 | 1.91B |
From Apr 2022 to Apr 2024
By Michael Susin
Indivior PLC said Friday that it has reached a confidential settlement with Dr. Reddy's Laboratories Ltd. to resolve all claims related to a patent litigation for a generic treatment for opioid addiction.
The U.K. pharmaceutical company said the amount of the settlement is consistent with its previously disclosed reserve amount.
Shares at 1057 GMT were up 6.4 pence, or 2.1%, at 309.6 pence.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
June 24, 2022 07:30 ET (11:30 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
